Group 1 - Pharming Group N.V. will participate in the Canaccord Genuity 45 Annual Growth Conference in Boston, USA, on August 12-13, 2025 [1] - CEO Fabrice Chouraqui will present on August 12 at 12:00pm EDT/18:00 CEST [1] - Investors can schedule one-to-one meetings with Pharming's management team through the Investor Relations team [1] Group 2 - Pharming Group N.V. is a global biopharmaceutical company focused on patients with rare, debilitating, and life-threatening diseases [2] - The company is involved in the commercialization and development of innovative medicines, including small molecules and biologics [2] - Pharming is headquartered in Leiden, the Netherlands, and operates in over 30 markets worldwide [2]

Company Overview - Pharming Group N.V. is a global biopharmaceutical company focused on transforming the lives of patients with rare, debilitating, and life-threatening diseases [5] - The company is involved in the commercialization and development of a portfolio of innovative medicines, including small molecules and biologics [5] - Pharming is headquartered in Leiden, the Netherlands, and operates in over 30 markets across North America, Europe, the Middle East, Africa, and Asia-Pacific [5] Upcoming Financial Results - Pharming will report its preliminary (unaudited) financial results for the second quarter and first half of 2025 on July 31, 2025 [1] - A business update will also be provided during the same announcement [1] - Management will host a conference call and webcast for analysts and investors at 13:30 CEST/07:30 am EDT on the same day [1]